bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.5120
+0.0173 (3.50%)
At close: Apr 24, 2025, 4:00 PM
0.5070
-0.0050 (-0.98%)
Pre-market: Apr 25, 2025, 6:07 AM EDT
bioAffinity Technologies Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for bioAffinity Technologies.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for bioAffinity Technologies is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|
Strong Buy | 1 | 1 | 0 |
Buy | 0 | 0 | 0 |
Hold | 0 | 0 | 1 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2025 |
Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +1,071.87% | Jul 23, 2024 |
Financial Forecast
Revenue This Year
6.17M
from 9.36M
Decreased by -34.13%
Revenue Next Year
7.40M
from 6.17M
Increased by 19.99%
EPS This Year
-0.67
from -0.75
EPS Next Year
-0.47
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 6.3M | 7.6M |
Avg | 6.2M | 7.4M |
Low | 5.9M | 7.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | -32.2% | 23.5% |
Avg | -34.1% | 20.0% |
Low | -36.7% | 15.3% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.69 | -0.48 |
Avg | -0.67 | -0.47 |
Low | -0.65 | -0.45 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.